Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125733462 | 12573346 | 2 | F | 20160628 | 20160823 | 20160720 | 20160831 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-059115 | BRISTOL MYERS SQUIBB | 43.47 | YR | M | Y | 0.00000 | 20160831 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125733462 | 12573346 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | UNK, QD | U | 21436 | QD | ||||||||
| 125733462 | 12573346 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | Oral | 500 MG, QD | U | 0 | 500 | MG | QD | ||||||
| 125733462 | 12573346 | 3 | SS | BUPRENORPHINE. | BUPRENORPHINE | 1 | Oral | 2 DF, QD | U | 0 | 2 | DF | QD | ||||||
| 125733462 | 12573346 | 4 | SS | DEPAMIDE | VALPROMIDE | 1 | Unknown | 300 MG, UNK | U | 0 | 300 | MG | TABLET | ||||||
| 125733462 | 12573346 | 5 | SS | LASILIX /00032601/ | FUROSEMIDE | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 125733462 | 12573346 | 6 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 2 DF, QD | U | 0 | 2 | DF | QD | ||||||
| 125733462 | 12573346 | 7 | SS | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125733462 | 12573346 | 8 | C | TRANSIPEG /00754501/ | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | UNK | U | 0 | |||||||||
| 125733462 | 12573346 | 9 | C | NICOPATCH | NICOTINE | 1 | Transdermal | U | 0 | TRANSDERMAL PATCH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125733462 | 12573346 | 1 | Product used for unknown indication |
| 125733462 | 12573346 | 2 | Schizophrenia |
| 125733462 | 12573346 | 3 | Product used for unknown indication |
| 125733462 | 12573346 | 4 | Product used for unknown indication |
| 125733462 | 12573346 | 5 | Product used for unknown indication |
| 125733462 | 12573346 | 6 | Hypertension |
| 125733462 | 12573346 | 7 | Product used for unknown indication |
| 125733462 | 12573346 | 8 | Constipation |
| 125733462 | 12573346 | 9 | Tobacco user |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125733462 | 12573346 | OT |
| 125733462 | 12573346 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125733462 | 12573346 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125733462 | 12573346 | 1 | 20151005 | 0 | ||
| 125733462 | 12573346 | 2 | 20151112 | 0 | ||
| 125733462 | 12573346 | 4 | 20151005 | 0 |